rxstat › Shortages › Zolmitriptan

Zolmitriptan shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Zolmitriptan products are in shortage in Canada (11 of 28 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jan 3, 2028.
Products affected
11 / 28
In shortage since
Oct 14, 2016
Est. full return
Jan 3, 2028
Reports on file
77
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
NRA-ZOLMITRIPTAN
2.5MG · TABLET · NORA PHARMA INC
DIN 02489392 · since Sep 10, 2024, est. end Jul 15, 2026 · Disruption of the manufacture of the drug.
Active shortage
SANDOZ ZOLMITRIPTAN ODT
2.5MG · TABLET (ORALLY DISINTEGRATING) · SANDOZ CANADA INCORPORATED
DIN 02362996 · since Jun 12, 2024, est. end Jan 3, 2028 · Disruption of the manufacture of the drug.
Active shortage
SANDOZ ZOLMITRIPTAN ODT
2.5MG · TABLET (ORALLY DISINTEGRATING) · SANDOZ CANADA INCORPORATED
DIN 02362996 · since Apr 23, 2024, est. end Jan 3, 2028 · Disruption of the manufacture of the drug.
Active shortage
SANDOZ ZOLMITRIPTAN
2.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02362988 · since Jun 9, 2025, est. end Jan 3, 2028 · Disruption of the manufacture of the drug.
Active shortage
SANDOZ ZOLMITRIPTAN
2.5MG · TABLET · SANDOZ CANADA INCORPORATED
DIN 02362988 · since May 5, 2025, est. end Jan 3, 2028 · Disruption of the manufacture of the drug.
Active shortage
ZOLMITRIPTAN
2.5MG · TABLET · SANIS HEALTH INC
DIN 02442655 · since Apr 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ZOLMITRIPTAN ODT
2.5MG · TABLET (ORALLY DISINTEGRATING) · SANIS HEALTH INC
DIN 02442671 · since Sep 11, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-ZOLMITRIPTAN OD
2.5MG · TABLET (ORALLY DISINTEGRATING) · TEVA CANADA LIMITED
DIN 02342545 · since Mar 18, 2022, no end estimate · Disruption of the manufacture of the drug.
Active shortage
JAMP ZOLMITRIPTAN
2.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02477106 · since Feb 9, 2022, est. end Dec 31, 2023 · Disruption of the manufacture of the drug.
Active shortage
JAMP-ZOLMITRIPTAN ODT
2.5MG · TABLET (ORALLY DISINTEGRATING) · JAMP PHARMA CORPORATION
DIN 02428237 · since Jan 8, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortage
JAMP-ZOLMITRIPTAN ODT
2.5MG · TABLET (ORALLY DISINTEGRATING) · JAMP PHARMA CORPORATION
DIN 02428237 · since Oct 12, 2018, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Active shortage
SEPTA-ZOLMITRIPTAN-ODT
2.5MG · TABLET (ORALLY DISINTEGRATING) · SEPTA PHARMACEUTICALS INC
DIN 02428474 · since Jun 27, 2017, no end estimate · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Zolmitriptan is currently affected by 11 active shortage reports filed with Health Canada by NORA PHARMA INC, SANDOZ CANADA INCORPORATED, SANIS HEALTH INC, TEVA CANADA LIMITED and 4 others.

The reported causes are: disruption of the manufacture of the drug; delay in shipping of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Zolmitriptan is classified under “ANTIMIGRAINE PREPARATIONS” (ATC N02CC).

Recent changes

Common questions

When will Zolmitriptan be back in stock in Canada?

The latest manufacturer estimate is Jan 3, 2028. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Zolmitriptan in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antimigraine preparations)

Partial shortageAlmotriptan1 of 10 reported products affected · est. return Jan 23, 2026Partial shortageEletriptan1 of 18 reported products affected · est. return Jul 28, 2026Partial shortagePizotifen1 of 1 reported products affected · est. return Jul 31, 2026Partial shortageRizatriptan9 of 37 reported products affected · est. return Dec 31, 2026No current shortageDihydroergotamineNo current shortageFrovatriptan

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.